Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Retained Earnings (Accumulated Deficit) 2010-2024 | EVO

Evotec AG retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
  
Evotec AG Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $-728
2023 $-515
2022 $-413
2021 $-256
2020 $-496
2019 $-494
2018 $-568
2017 $-641
2016 $-656
2015 $-691
2014 $-849
2013 $-839
2012 $-780
2011 $-848
2010 $0
2009 $-863
Evotec AG Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-12-31 $-728
2024-09-30 $-694
2024-06-30 $-637
2024-03-31 $-540
2023-09-30 $-526
2023-06-30 $-489
2022-12-31 $-413
2022-09-30 $-367
2022-06-30 $-338
2022-03-31 $-325
2021-12-31 $-256
2021-09-30 $-220
2021-06-30 $-386
2021-03-31 $-460
2020-12-31 $-496
2020-09-30 $-509
2020-06-30 $-478
2020-03-31 $-473
2019-12-31 $-494
2019-09-30 $-499
2019-06-30 $-527
2019-03-31 $-529
2018-12-31 $-568
2018-09-30 $-596
2018-06-30 $-654
2018-03-31 $-691
2017-12-31 $-641
2017-09-30 $-681
2017-06-30 $-641
2017-03-31 $-624
2016-12-31 $-656
2016-09-30 $-681
2016-06-30 $-699
2016-03-31 $-687
2015-12-31 $-691
2015-09-30 $-699
2015-06-30 $-692
2015-03-31 $-722
2014-12-31 $-849
2014-09-30 $-849
2014-06-30 $-873
2014-03-31 $-871
2013-12-31 $-839
2013-09-30 $-810
2013-06-30 $-798
2013-03-31 $-805
2012-12-31 $-780
2012-09-30 $-753
2012-06-30 $-780
2012-03-31 $-801
2011-12-31 $-848
2011-09-30 $-859
2011-06-30 $-885
2011-03-31 $-842
2010-12-31
2010-09-30 $-797
2010-06-30 $-790
2010-03-31 $-859
2009-12-31 $-863
2009-09-30 $-868
2009-06-30 $-35
2009-03-31 $-812
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.399B $0.862B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $84.579B 31.73
Zoetis (ZTS) United States $71.389B 26.64
Takeda Pharmaceutical (TAK) Japan $44.547B 8.86
Daiichi Sankyo, - (DSNKY) Japan $44.407B 22.59
Sandoz Group AG (SDZNY) Switzerland $20.218B 0.00
Summit Therapeutics (SMMT) United States $17.148B 0.00
Merck (MKKGY) Germany $16.879B 12.37
United Therapeutics (UTHR) United States $13.709B 12.13
Shionogi (SGIOY) Japan $12.740B 12.76
Neurocrine Biosciences (NBIX) United States $11.903B 40.77
IPSEN (IPSEY) France $9.572B 0.00
Orion OYJ (ORINY) Finland $8.544B 23.11
Corcept Therapeutics (CORT) United States $7.779B 63.24
Stevanato Group S.p.A (STVN) Italy $7.062B 43.19
Madrigal Pharmaceuticals (MDGL) United States $6.479B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.976B 0.00
Grifols, S.A (GRFS) Spain $5.397B 0.00
Ionis Pharmaceuticals (IONS) United States $5.251B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.040B 15.33
Soleno Therapeutics (SLNO) United States $3.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.922B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.901B 10.16
Hypermarcas (HYPMY) Brazil $2.869B 18.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.351B 12.71
BioCryst Pharmaceuticals (BCRX) United States $2.136B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.054B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.728B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.682B 0.00
Guardian Pharmacy Services (GRDN) United States $1.577B 0.00
Indivior (INDV) United States $1.526B 6.47
Dyne Therapeutics (DYN) United States $1.334B 0.00
ARS Pharmaceuticals (SPRY) United States $1.198B 0.00
Ocular Therapeutix (OCUL) United States $1.142B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Collegium Pharmaceutical (COLL) United States $0.943B 5.08
Harrow (HROW) United States $0.940B 0.00
Enliven Therapeutics (ELVN) United States $0.874B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.860B 0.00
Ardelyx (ARDX) United States $0.809B 0.00
Cronos Group (CRON) Canada $0.802B 0.00
Xeris Biopharma Holdings (XERS) United States $0.749B 0.00
AleAnna (ANNA) United States $0.700B 0.00
Akebia Therapeutics (AKBA) United States $0.667B 0.00
Xencor (XNCR) United States $0.584B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
USANA Health Sciences (USNA) United States $0.559B 12.15
Regulus Therapeutics (RGLS) United States $0.543B 0.00
Savara (SVRA) United States $0.538B 0.00
Bioventus (BVS) United States $0.537B 13.62
CytoDyn (CYDY) United States $0.505B 0.00
Elite Pharmaceuticals (ELTP) United States $0.482B 0.00
Relay Therapeutics (RLAY) United States $0.478B 0.00
Altimmune (ALT) United States $0.469B 0.00
Zevra Therapeutics (ZVRA) United States $0.461B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.457B 0.00
Siga Technologies (SIGA) United States $0.423B 8.84
Amylyx Pharmaceuticals (AMLX) United States $0.403B 0.00
Tourmaline Bio (TRML) United States $0.399B 0.00
Verve Therapeutics (VERV) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.384B 0.00
Oruka Therapeutics (ORKA) United States $0.354B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.353B 9.54
Heron Therapeutics (HRTX) United States $0.285B 0.00
Nature's Sunshine Products (NATR) United States $0.270B 24.90
ProKidney (PROK) United States $0.249B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
OmniAb (OABI) United States $0.189B 0.00
Nanobiotix S.A (NBTX) France $0.173B 0.00
Liminatus Pharma (LIMN) $0.172B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.168B 0.00
Wellgistics Health (WGRX) United States $0.167B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Esperion Therapeutics (ESPR) United States $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.151B 0.00
4D Molecular Therapeutics (FDMT) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.136B 0.00
Korro Bio (KRRO) United States $0.136B 0.00
Aclaris Therapeutics (ACRS) United States $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Nektar Therapeutics (NKTR) United States $0.127B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.120B 0.00
Lyell Immunopharma (LYEL) United States $0.119B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.115B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
VAXART, INC (VXRT) United States $0.097B 0.00
OptiNose (OPTN) United States $0.096B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.096B 0.00
Achieve Life Sciences (ACHV) Canada $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.094B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 14.27
Galectin Therapeutics (GALT) United States $0.083B 0.00
Dominari Holdings (DOMH) United States $0.082B 0.00
Fractyl Health (GUTS) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 58.22
ESSA Pharma (EPIX) Canada $0.076B 0.00
Telomir Pharmaceuticals (TELO) United States $0.070B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Pyxis Oncology (PYXS) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Unicycive Therapeutics (UNCY) United States $0.066B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.061B 0.00
Vivani Medical (VANI) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Surrozen (SRZN) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Karyopharm Therapeutics (KPTI) United States $0.047B 0.00
Century Therapeutics (IPSC) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
PMV Pharmaceuticals (PMVP) United States $0.044B 0.00
Avalo Therapeutics (AVTX) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Mannatech (MTEX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Jupiter Neurosciences (JUNS) United States $0.020B 0.00
Lipocine (LPCN) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Relmada Therapeutics (RLMD) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.90
BioLineRx (BLRX) Israel $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.008B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Traws Pharma (TRAW) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Incannex Healthcare (IXHL) Australia $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00